Pharmacogenomics of Mood Disorder in Chronic Kidney Disease Patients
NCT06675396 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2024-11-05
Summary
By using genetic information we could predict the prevalence of mood disorder and response to treatment.
Conditions
- Chronic Kidney Disease(CKD)
- Depression
Interventions
- OTHER
-
Antidepressants
control
Sponsors & Collaborators
-
Wonju Severance Christian Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-12-01
- Primary Completion
- 2026-12-31
- Completion
- 2028-12-31
More Related Trials
-
Impact and Mechanism of Depression on Cardio-cerebral Vascular Events and Arteriovenous Fistula Dysfunction in MHD Patients
NCT06070805 ·Status: COMPLETED
-
Development of Systems and Precision Medicine - Take Mood Disorder as an Example.
NCT04483661 ·Status: UNKNOWN
-
Mental Health Mission Mood Disorder Cohort Study
NCT07189689 ·Status: NOT_YET_RECRUITING
-
Integrating Pharmacogenomic Testing Into a Child Psychiatry Clinic
NCT02855580 ·Status: COMPLETED
-
Cytochrome P450-2D6 Screening Among Elderly Using Antidepressants (CYSCE)
NCT01778907 ·Status: COMPLETED ·Phase: PHASE4
-
Predictors of Cognitive Outcomes in Geriatric Depression
NCT05273996 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
A Single-center Randomized Controlled Study on the Effect of Pharmacogenomics Trial on Clinical Efficacy in Patients With Depression
NCT05959187 ·Status: COMPLETED ·Phase: NA
-
Neurocognitive Outcomes of Depression in the Elderly
NCT00570583 ·Status: COMPLETED
-
Optimal Dose of a Cognitive Control Training for Depression Vulnerability
NCT05166798 ·Status: COMPLETED ·Phase: NA
-
Identifying and Treating Depression in Hemodialysis Patients
NCT03390933 ·Status: COMPLETED ·Phase: PHASE4
-
Combination of Novel Therapies for CKD Comorbid Depression
NCT04422652 ·Status: RECRUITING ·Phase: PHASE2
-
Prediction of REsponse to Depression Interventions Using Clinical and TD-fNIRS Measurements
NCT06002100 ·Status: ENROLLING_BY_INVITATION
-
CYP1A2, ABCB1, CYP2C9 and Plasma Concentration of Agomelatine in Adult Patients With Depression
NCT06120543 ·Status: UNKNOWN
-
Pharmacogenetic and Antidepressant Treatment in Elderly
NCT02856477 ·Status: TERMINATED ·Phase: NA
-
Mood and Cognitive Outcome After Heart Transplantation (the MOODHEART Study)
NCT02035865 ·Status: COMPLETED
-
Epigenetic Regulation of BDNF in Major Depression
NCT01182103 ·Status: COMPLETED
-
Precision Medicine in the Depression Treatment
NCT05616559 ·Status: RECRUITING
-
Study of the Neural Circuits Underlying the Negative Emotional Bias of Depressive Disorders and Their Response to Ketamine
NCT06630065 ·Status: RECRUITING ·Phase: NA
-
Psychopharmacotherapy for Depressive Patients
NCT06054321 ·Status: RECRUITING ·Phase: NA
-
Pathophysiology of Neurodegeneration in Late-life Depression (AV45+THK)
NCT03430869 ·Status: COMPLETED ·Phase: PHASE2
-
Action Tendencies and Prognosis in Major Depressive Disorder
NCT04593537 ·Status: COMPLETED
-
Establish a Specific Cohort Database for Depressive Disorders
NCT05095662 ·Status: ACTIVE_NOT_RECRUITING
-
A One-year Trajectory of Depression Status Changes in Older Adults With MCI and SD: a Longitudinal Cohort Study
NCT06308627 ·Status: COMPLETED
-
Lifestyle Interventions to Prevent Cognitive Deficits in Subjects With Depressive Symptoms: From Mechanisms to Clinical Practice
NCT07009223 ·Status: RECRUITING ·Phase: NA
-
Making Decisions About Depression Medications
NCT01502891 ·Status: COMPLETED ·Phase: NA